Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Metronidazole, Diltiazem and Lidocaine for Post-Haemorrhoidectomy Pain
NCT04276298Phase 3Completed
- Sponsor
- The University of Auckland
- Start
- Sep 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metronidazole, DOLIZEM, lidocaine 10% oropharyngeal spray in postoperative pain, sponsored by The University of Auckland. Started Sep 2020; status: completed.
02
Drugs
metronidazoleDOLIZEMlidocaine 10% oropharyngeal spray
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04276298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04276298.